Price (90d)
$11.14Signal Score (90d)
98Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $475.68M | $78.33M | $0.32 |
| 2024 | $401.20M | $-283.01M | $-1.35 |
| 2023 | $325.11M | $-81.10M | $-0.43 |
| 2022 | $270.65M | $120.81M | $0.64 |
| 2021 | $246.25M | $71.40M | $0.50 |
Social Signal Score
Earnings
Wed, Nov 11(in 3 months)
Consensus estimate $0.17 per share
Typical surprise +20.0% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 13$0.11 vs $0.06beat
- Thu, May 14$0.04 vs $0.05miss
- Wed, Feb 11$0.09 vs $0.14miss
- Wed, Nov 12$0.14 vs $0.09beat
- Thu, Aug 14$0.12 vs $0.10beat
- Wed, May 14$0.10 vs $0.05beat
Estimates and results for CLBT via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from CLBT's reported EPS growth of -10.6% a year over 4 years.
- EPS in 5 years
- $0.18
- Implied price
- $9.91
- Return from $11.14
- -2.3% a year
To earn 15.0% a year on these assumptions you'd need to buy at $4.93 — -55.8% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 40 | 48 | 56 | 64 | 72 |
|---|---|---|---|---|---|
| -20.6% | -18.9% | -15.9% | -13.2% | -10.9% | -8.8% |
| -15.6% | -13.8% | -10.6% | -7.8% | -5.3% | -3.0% |
| -10.6% | -8.7% | -5.3% | -2.3% | 0.3% | 2.7% |
| -5.6% | -3.6% | 0.0% | 3.2% | 6.0% | 8.5% |
| -0.6% | 1.6% | 5.3% | 8.6% | 11.6% | 14.2% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (8)
- Newsprnewswire.com·1d ago·Neutral
Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT) Cellebrite DI Ltd. (CLBT) shareholders lost money when the stock sold off more than 30% following the Company's Q2 2026 results -- Levi & Korsinsky is investigating the Company's disclosures concerning their previous projections and related discussions.
View source ↗ - Newsnewsfilecorp.com·1d ago·Positive
Kaplan Fox Alerts Investors of Cellebrite DI Ltd. (CLBT) to an Investigation of Potential Securities Law Violations New York, New York--(Newsfile Corp. - August 13, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
View source ↗ - Newsseekingalpha.com·1d ago·Positive
Cellebrite DI Ltd. (CLBT) Q2 2026 Earnings Call Transcript Cellebrite DI Ltd. (CLBT) Q2 2026 Earnings Call Transcript
View source ↗ - Newsprnewswire.com·2d ago·Negative
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Cellebrite DI Ltd. MILWAUKEE, Aug. 13, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Cellebrite (NASDAQ: CLBT). The investigation results from inaccurate statements Cellebrite may have made regarding its financial statements, business operations and prospects.
View source ↗ - Newsnewsfilecorp.com·2d ago·Negative
CLBT INVESTIGATION: Cellebrite DI Investigated for Securities Fraud by Block & Leviton; Investors Should Contact the Firm to Possibly Recover Losses Boston, Massachusetts--(Newsfile Corp. - August 13, 2026) - Block & Leviton is investigating Cellebrite DI (NASDAQ: CLBT) for potential securities law violations. Investors who have lost money in their Cellebrite DI investment should contact the firm to learn more about how they might recover those losses.
View source ↗ - Newsmarketbeat.com·2d ago·Neutral
Cellebrite DI Q2 Earnings Call Highlights Cellebrite DI NASDAQ: CLBT reported second-quarter results that fell short of its expectations for annual recurring revenue, citing delayed large transactions, slower-than-anticipated pricing and expansion gains from customer migrations, and added procurement requirements for cloud and artificial intelligence offerings. The company lowered its full-year ARR and revenue outlook while raising its adjusted EBITDA target.
View source ↗ - Newszacks.com·2d ago·Negative
Cellebrite DI Ltd. (CLBT) Q2 Earnings and Revenues Miss Estimates Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.11 per share, missing the Zacks Consensus Estimate of $0.12 per share.
View source ↗ - Newsprnewswire.com·2d ago·Neutral
Cellebrite Appoints Shiven Ramji Chief Executive Officer, Succeeding Thomas E. Hogan Company Reports Second-Quarter 2026 Results ; Company Lowers Full-Year 2026 ARR and Revenue Outlook and Raises Adjusted EBITDA Target TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 13, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
View source ↗